{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-26-000028","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2026-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.953549+00:00","generated_at":"2026-05-14T19:42:23.092659+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Edwards shareholders approve 7M share increase in Long-Term Stock Program","bullets":["Stockholders authorized 7M additional shares, raising total available to 341.5M under the amended program.","All 9 director nominees reelected; proposal received between 428M and 474M For votes each.","Advisory vote on named executive officer compensation passed with ~89% of votes cast.","Ratification of PwC as independent auditor for FY2026 approved with ~89% of votes cast.","Stock program amendment (Proposal 4) passed with 456.7M For (96% of votes cast, excluding broker non-votes)."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-26-000028","json":"https://secwatch.observer/filing/0001099800-26-000028.json","markdown":"https://secwatch.observer/filing/0001099800-26-000028.md","text":"https://secwatch.observer/filing/0001099800-26-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000028/0001099800-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000028/ew-20260507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T19:42:23.092659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}